239 related articles for article (PubMed ID: 24744215)
21. [Nephrolithiasis of adult: From mechanisms to preventive medical treatment].
Courbebaisse M; Prot-Bertoye C; Bertocchio JP; Baron S; Maruani G; Briand S; Daudon M; Houillier P
Rev Med Interne; 2017 Jan; 38(1):44-52. PubMed ID: 27349612
[TBL] [Abstract][Full Text] [Related]
22. Pathophysiology and clinical aspects of urinary lithiasis.
Vella M; Karydi M; Coraci G; Oriti R; Melloni D
Urol Int; 2007; 79 Suppl 1():26-31. PubMed ID: 17726349
[TBL] [Abstract][Full Text] [Related]
23. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
24. Etiology and treatment of urolithiasis.
Pak CY
Am J Kidney Dis; 1991 Dec; 18(6):624-37. PubMed ID: 1962646
[TBL] [Abstract][Full Text] [Related]
25. Nephrolithiasis in Cushing's disease: prevalence, etiopathogenesis, and modification after disease cure.
Faggiano A; Pivonello R; Melis D; Filippella M; Di Somma C; Petretta M; Lombardi G; Colao A
J Clin Endocrinol Metab; 2003 May; 88(5):2076-80. PubMed ID: 12727957
[TBL] [Abstract][Full Text] [Related]
26. Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets.
Noori N; Honarkar E; Goldfarb DS; Kalantar-Zadeh K; Taheri M; Shakhssalim N; Parvin M; Basiri A
Am J Kidney Dis; 2014 Mar; 63(3):456-63. PubMed ID: 24560157
[TBL] [Abstract][Full Text] [Related]
27. [Metabolic changes in 2612 patients with nephrolithiasis].
del Valle E; Spivacow R; Zanchetta JR
Medicina (B Aires); 1999; 59(5 Pt 1):417-22. PubMed ID: 10684159
[TBL] [Abstract][Full Text] [Related]
28. [Citrate and renal stones].
del Valle EE; Spivacow FR; Negri AL
Medicina (B Aires); 2013; 73(4):363-8. PubMed ID: 23924538
[TBL] [Abstract][Full Text] [Related]
29. [Pathophysiology, diagnosis and conservative therapy of non-calcium kidney calculi].
Hochreiter W; Knoll T; Hess B
Ther Umsch; 2003 Feb; 60(2):89-97. PubMed ID: 12649987
[TBL] [Abstract][Full Text] [Related]
30. Nephrolithiasis.
Worcester EM; Coe FL
Prim Care; 2008 Jun; 35(2):369-91, vii. PubMed ID: 18486720
[TBL] [Abstract][Full Text] [Related]
31. Metabolic factors associated with urinary calculi in children.
Naseri M; Varasteh AR; Alamdaran SA
Iran J Kidney Dis; 2010 Jan; 4(1):32-8. PubMed ID: 20081302
[TBL] [Abstract][Full Text] [Related]
32. [Incidence of hyperoxaluria in idiopathic calcium nephrolithiasis].
Jaeger P; Portmann L; Bugnon JM; Jacquet AF; Burckhardt P
Schweiz Med Wochenschr; 1982 Dec; 112(49):1795-8. PubMed ID: 7178877
[TBL] [Abstract][Full Text] [Related]
33. The association of dietary inflammatory index with urinary risk factors of kidney stones formation in men with nephrolithiasis.
Maddahi N; Yarizadeh H; Aghamir SMK; Alizadeh S; Yekaninejad MS; Mirzaei K
BMC Res Notes; 2020 Aug; 13(1):373. PubMed ID: 32771046
[TBL] [Abstract][Full Text] [Related]
34. The spectrum of metabolic abnormalities in patients with cystine nephrolithiasis.
Sakhaee K; Poindexter JR; Pak CY
J Urol; 1989 Apr; 141(4):819-21. PubMed ID: 2926871
[TBL] [Abstract][Full Text] [Related]
35. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in the pathophysiology of nephrolithiasis.
Sakhaee K
Kidney Int; 2009 Mar; 75(6):585-95. PubMed ID: 19078968
[TBL] [Abstract][Full Text] [Related]
37. Effect of cystine-binding thiol drugs on urinary cystine capacity in patients with cystinuria.
Dolin DJ; Asplin JR; Flagel L; Grasso M; Goldfarb DS
J Endourol; 2005 Apr; 19(3):429-32. PubMed ID: 15865542
[TBL] [Abstract][Full Text] [Related]
38. Renal stone disease: Causes, evaluation and medical treatment.
Heilberg IP; Schor N
Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):823-31. PubMed ID: 17117307
[TBL] [Abstract][Full Text] [Related]
39. Bone disease in medullary sponge kidney and effect of potassium citrate treatment.
Fabris A; Bernich P; Abaterusso C; Marchionna N; Canciani C; Nouvenne A; Zamboni M; Lupo A; Gambaro G
Clin J Am Soc Nephrol; 2009 Dec; 4(12):1974-9. PubMed ID: 19808216
[TBL] [Abstract][Full Text] [Related]
40. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
